Check the background of this firm on FINRA's BrokerCheck.

Leigh Baldwin & Co.

112 Albany Street, Cazenovia, NY 13035 | Phone: (315) 655-2964 Toll Free: 1-800-659-8044

Check the background of this firm on FINRA's BrokerCheck.

Diamonds and Dogs

3/5/2013

Impax Laboratories Inc. (IPXL)
Impax Labs is getting crushed today, down 26.00% at $14.80. The biopharmaceutical company saw shares fall after announcing an update on the FDA's inspection of the company's facility. The FDA inspected Impax's Hayward, California facility and found 12 points of concern. Three of these concerns were repeat violations that the FDA had warned Impax to fix in 2011. The main concern for the FDA was the company's manufacturing deficiencies, which can cause huge problems for any company, especially a biopharmaceutical company. After the news, analysts from Canaccord downgraded the company from buy to hold. Impax set a new 52-week low today, dropping past its previous low of $18.90.

Cree Inc. (CREE)
Cree and the Dow Jones are both setting new highs today, with Cree up 14.38% at $51.15. The LED lighting company saw its shares explode after increasing its forecast and announcing a release of a new light bulb. The company announced that it would sell a LED light bulb for under $10 at Home Depot. The cost efficient LED bulb is seen as a ground-breaking product for the company. Breaking the $10 price range for the LED bulb will help to sway consumers into switching from incandescent bulbs to the energy efficient LED bulb's. Management feels the bulb will help to increase revenue, as such the company increased their forecast for revenue from a range of $325-345 million to a range of $335-350 million. Cree set a new 52-week high today by over $4.00.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.